Mouse models of prostate carcinogenesis.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Trends in Genetics

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0168-9525(02)02683-5PMID 12047956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis

  2002cited by this paper
• Transgenic Mouse Models of Prostate Cancer

  2001cited by this paper
• Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

  2001cited by this paper
• Transgenics in Endocrinology

  2001cited by this paper
• Autochthonous mouse models for prostate cancer: past, present and future.

  2001cited by this paper
• A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.

  2001cited by this paper
• Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation.

  2001cited by this paper
• Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter

  2001cited by this paper
• Xenograft Models and the Molecular Biology of Human Prostate Cancer

  2001cited by this paper
• Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

  2001cited by this paper
• Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice.

  2000cited by this paper
• Prostate specific expression of Cre recombinase in transgenic mice

  2000cited by this paper
• The multiple roles of PTEN in tumor suppression.

  2000cited by this paper
• Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice.

  2000cited by this paper
• Prostatic neoplasia in transgenic mice with prostate‐directed overexpression of the c‐myc oncoprotein

  2000cited by this paper
• Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

  2000cited by this paper
• Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant prostatic disease

  2000cited by this paper
• Chemoprevention of prostate carcinogenesis by α-difluoromethylornithine in TRAMP mice

  2000cited by this paper
• High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

  2000cited by this paper
• E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.

  2000cited by this paper
• Molecular genetics of prostate cancer.

  2000cited by this paper
• Roles for Nkx3.1 in prostate development and cancer.

  1999cited by this paper
• New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

  1999cited by this paper
• Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.

  1999cited by this paper
• The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.

  1999cited by this paper
• Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

  1998cited by this paper
• Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth

  1998cited by this paper
• Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.

  1998cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.

  1998cited by this paper
• Peptide Growth Factors and Prostate Cancer: New Models, New Opportunities

  1998cited by this paper
• The C3(1)/SV40 T Antigen Transgenic Mouse Model of Prostate and Mammary Cancer

  1998cited by this paper
• Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice

  1997cited by this paper
• A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.

  1997cited by this paper
• Prostate cancer progression, metastasis, and gene expression in transgenic mice.

  1997cited by this paper
• Androgen-independent prostate cancer progression in the TRAMP model.

  1997cited by this paper
• Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms.

  1995cited by this paper
• Prostate cancer in a transgenic mouse.

  1995cited by this paper
• Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

  1994cited by this paper
• Restriction of neuroblastoma to the prostate gland in transgenic mice

  1991cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Small Composite Probasin Promoter Confers High Levels of Prostate-Specific Gene Expression through Regulation by Androgens and Glucocorticoids in Vitro and in Vivo*

  year unknowncited by this paper

• Use of Natural Products and Their Derivative in Cancer Research for the Discovery of Safer Treatments

  2022cites this paper
• Prostate cancer

  2021cites this paper
• An overview of the latest in state-of-the-art murine models for prostate cancer

  2021cites this paper
• Verbascoside—A Review of Its Antitumor Activities

  2021cites this paper
• Preclinical Animal Models for Cancer Research and Drug Discovery

  2019cites this paper
• Cell & Molecular Biology of Prostate Cancer

  2018cites this paper
• CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.

  2018cites this paper
• Inflammation and Prostate Cancer.

  2018cites this paper
• Advancements in Tumor Immunotherapy and Cancer Vaccines 38 preclinical studies

  2017cites this paper
• Therapeutic Approaches Targeting MYC-Driven Prostate Cancer

  2017cites this paper
• Effects of L-Glutamine oral supplementation on prostate of irradiated rats

  2016cites this paper
• Histochemical evaluation of postnatal lectin-binding sites in the mouse prostate.

  2016cites this paper
• Characterization of a novel metastatic prostate cancer cell line of LNCaP origin

  2016cites this paper
• Regulation of local steroidogenesis in the brain and in prostate cancer: lessons learned from interdisciplinary collaboration.

  2015cites this paper
• Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics

  2015cites this paper
• Transgene verification and technical improvement in the establisment of transgenic miR-32 mouse line

  2015cites this paper
• Context-Dependent Interaction of the Androgen Receptor with Oncogenic Pathways Common to Prostate Cancer.

  2015cites this paper
• Fibroblast Growth Factor Signaling in Prostate Stem Cells and Prostate Cancer

  2015cites this paper
• Androgens and calcium-binding protein regucalcin in the control of prostate cells metabolism and survival: implications in carcinogenesis.

  2015cites this paper
• In vitro and in vivo model systems used in prostate cancer research.

  2015cites this paper
• FUNCTIONAL IN VIVO SCREEN IDENTIFIES PYGO2 AS A PUTATIVE GENE TO PROMOTE PROSTATE CANCER

  2015influential citation
• Chapter-10 Prostate Cancer

  2014cites this paper
• New concepts concerning prostate cancer screening

  2014cites this paper
• A general synthetic strategy and the anti-proliferation properties on prostate cancer cell lines for natural phenylethanoid glycosides.

  2014cites this paper
• Bisphenol A effects in transthyretin and barrier integrity markers in the choroid plexus

  2014cites this paper
• Exploration of a xenograft model of human prostate cancer to predict patient treatment response

  2014cites this paper
• Untersuchungen zum Verständnis der biologischen Funktion des eukaryotischen Initiationsfaktors 5A (eIF-5A) und dessen Hypusinmodifikation

  2013cites this paper
• ANIMAL MODELS OF CANCER: A REVIEW

  2013cites this paper
• Foxm1 Expression in Prostate Epithelial Cells Is Essential for Prostate Carcinogenesis*

  2013cites this paper
• Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development

  2013cites this paper
• FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.

  2013influential citation
• Challenges to Prostate Cancer Immunotherapy

  2012cites this paper
• Modeling prostate cancer in mice: limitations and opportunities.

  2012cites this paper
• In vivo elucidation of PIM kinase role in tumourigenesis

  2012cites this paper
• A Hoxb13‐driven reverse tetracycline transactivator system for conditional gene expression in the prostate

  2012cites this paper
• Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.

  2012cites this paper
• Tea polyphenols as prostate cancer preventive agents

  2011cites this paper
• Preclinical Development Characterization of the Oncogenic Activity of the Novel TRIM 59 Gene in Mouse Cancer Models

  2011cites this paper
• Mouse Models of Prostate Cancer

  2011cites this paper
• The impact of APE/Ref-1 on hypoxia regulated genes; potential applications for cancer

  2011cites this paper
• Characterization of the Oncogenic Activity of the Novel TRIM59 Gene in Mouse Cancer Models

  2011cites this paper
• UGT2B15, une cible pharmacologique dans le traitement du cancer de la prostate : étude Ex vivo et mise en place de modèles In vivo

  2011influential citation
• Effect of Regucalcin on the expression of oncogenes and tumor suppressor genes in prostate cell lines

  2010cites this paper
• Modeling prostate cancer: a perspective on transgenic mouse models

  2010cites this paper
• An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB

  2010cites this paper
• Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.

  2010cites this paper
• Cancer Stem Cells and Microenvironment in Prostate Cancer Progression

  2010cites this paper
• Sonic Hedgehog pathway activity in prostate cancer.

  2010cites this paper
• Biology and pathophysiology of the new human retrovirus XMRV and its association with human disease

  2010cites this paper
• PROSTATE CANCER CHEMOPREVENTION BY DIETARY PHYTOCHEMICALS

  2009cites this paper
• Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model.

  2009cites this paper
• Cancer vaccines: Uses of HLA transgenic mice compared to genetically modified mice.

  2009cites this paper
• Stromal growth and epithelial cell proliferation in ventral prostates of liver X receptor knockout mice

  2009cites this paper
• Prostate Stem Cells and Cancer in Animals

  2009cites this paper
• Dietary soy and green tea in the prevention of prostate cancer

  2009cites this paper
• Development of a Mouse Model for Prostate Cancer Imaging and Study of Disease Progression

  2009cites this paper
• Molecular Targeted Enhanced Ultrasound Imaging of Flk1 Reveals Diagnosis and Prognosis Potential in a Genetically Engineered Mouse Prostate Cancer Model

  2009cites this paper
• Characterization of preclinical models of prostate cancer using PET-based molecular imaging

  2009cites this paper
• The role of murine models of prostate cancer in drug target discovery and validation

  2009cites this paper
• Animal Models of Prostate Cancer

  2008cites this paper
• Genetically engineered mouse models of prostate cancer

  2008cites this paper
• Advances in mouse models of prostate cancer

  2008cites this paper
• Immortalized mouse epithelial cell models to study the role of apoptosis in cancer.

  2008cites this paper
• The Pace of Prostatic Intraepithelial Neoplasia Development Is Determined by the Timing of Pten Tumor Suppressor Gene Excision

  2008cites this paper
• BRAF Activation Initiates but Does Not Maintain Invasive Prostate Adenocarcinoma

  2008cites this paper
• Murine Prostate Cancer Inhibition by Dietary Phytochemicals—Curcumin and Phenyethylisothiocyanate

  2008cites this paper
• Temporally controlled prostate epithelium‐specific gene alterations

  2008cites this paper
• Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

  2008cites this paper
• An update on the xenograft and mouse models suitable for investigating new therapeutic compounds for the treatment of B-cell malignancies.

  2008cites this paper
• Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma

  2008cites this paper
• Gene expression profiling in the developing prostate.

  2008cites this paper
• Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells.

  2008cites this paper
• Interaction Between Dietary Factors and Inflammation in Prostate Carcinogenesis

  2008cites this paper
• Award Number: W81XWH-07-1-0150 TITLE: Role of MAPK activation in Prostate Cancer Development and Progression

  2008cites this paper
• THE SEARCH FOR GENES WHICH INFLUENCE PROSTATE CANCER METASTASIS: A MOVING TARGET?

  2008cites this paper
• Role of MAPK Activation in Prostate Cancer Development and Progression

  2008cites this paper
• Prostatic Secretory Protein of 94 Amino Acids Gene-Directed Transgenic Prostate Cancer: Three-Dimensional Ultrasound Microimaging

  2008cites this paper
• Development and characterisation of novel mouse models of human prostate cancer

  2008cites this paper
• Étude de l'impact des récepteurs non stéroïdiens sur l'activité androgénique dans les cellules cancéreuses de la prostate

  2008cites this paper
• Metastasis of prostate cancer

  2007cites this paper
• Chemopreventive and Bioenergetic Signaling Effects of PDK1/Akt Pathway Inhibition in a Transgenic Mouse Model of Prostate Cancer

  2007cites this paper
• Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound.

  2007cites this paper
• Prostate cancer: Re-focusing on androgen receptor signaling.

  2007cites this paper
• Progression of Prostate Cancer from a Subset of p63-Positive Basal Epithelial Cells in FG/Tag Transgenic Mice

  2007cites this paper
• Inactivation of Apc in the mouse prostate causes prostate carcinoma.

  2007influential citation
• Inflammation in prostate carcinogenesis

  2007cites this paper
• TREATMENT OF LOCALIZED PROSTATE CANCER USING HIGH‐INTENSITY FOCUSED ULTRASOUND

  2006cites this paper
• NANOTECHNOLOGY: POTENTIAL APPLICATIONS IN UROLOGY

  2006cites this paper
• Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.

  2006cites this paper
• IMMEDIATE ADMINISTRATION OF INTRAVESICAL MITOMYCIN C AFTER TUMOUR RESECTION FOR SUPERFICIAL BLADDER CANCER

  2006cites this paper
• ENDOSCOPIC TREATMENT WITH POLYDIMETHYLSILOXANE IN CHILDREN WITH DILATING VESICO‐URETERIC REFLUX

  2006cites this paper
• Bub 1 Up-Regulation and Hyperphosphorylation Promote Malignant Transformation in SV 40 Tag – Induced Transgenic Mouse Models

  2006cites this paper
• A mouse prostate cancer model induced by Hedgehog overexpression.

  2006influential citation
• THE STILUS (SURGICAL TRAINEES INTERESTED IN LAPAROSCOPIC AND ROBOTIC UROLOGICAL SURGERY) GROUP

  2006cites this paper
• Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model

  2006cites this paper
• Histopathology as a predictive biomarker: strengths and limitations.

  2006cites this paper
• Side‐effects of treatments for locally advanced prostate cancer

  2006cites this paper
• Histopathological characteristics of a novel knock-in mouse prostate cancer model.

  2006cites this paper
• Harnessing preclinical mouse models to inform human clinical cancer trials.

  2006cites this paper
• Identification of prostatic-secreted proteins in mice by mass spectrometric analysis and evaluation of lobe-specific and androgen-dependent mRNA expression.

  2006cites this paper